Impact of medication reconciliation for patients enrolled in oncology early phases clinical trials: A drug-drug interactions retrospective study

被引：1
|
作者：
Malifarge, L. [1 ]
Deppenweiler, M. [1 ]
Italiano, A. [2 ]
Lortal, B. [1 ]
机构：
[1] Inst Bergonie, Pharm, Bordeaux, France
[2] Inst Bergonie, Early Phase Trials Unit, Bordeaux, France
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.1489
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1842P
引用
收藏
页码：S1057 / S1057
页数：1
相关论文
共 50 条
  • [1] Impact of Medication Reconciliation in Oncology Early Phase Studies: A Drug-Drug Interaction Retrospective Study
    Malifarge, Laura
    Deppenweiler, Marine
    Italiano, Antoine
    Lortal, Barbara
    JCO ONCOLOGY PRACTICE, 2024, 20 (03) : 386 - 392
  • [2] Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials
    Lauren A. Marcath
    Taylor D. Coe
    Emily K. Hoylman
    Bruce G. Redman
    Daniel L. Hertz
    BMC Cancer, 18
  • [3] Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials
    Marcath, Lauren A.
    Coe, Taylor D.
    Hoylman, Emily K.
    Redman, Bruce G.
    Hertz, Daniel L.
    BMC CANCER, 2018, 18
  • [4] Prevalence of clinically relevant drug-drug interactions in patients enrolled in NCTN clinical trials.
    Marcath, Lauren A.
    Coe, Taylor D.
    Hoylman, Emily K.
    Redman, Bruce G.
    Hertz, Daniel Louis
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] Drug-drug interactions in subjects enrolled in SWOG trials of oral chemotherapy
    Marcath, Lauren A.
    Finley, Colin M.
    Wong, Siu Fun
    Hertz, Daniel L.
    BMC CANCER, 2021, 21 (01)
  • [6] Drug-drug interactions in subjects enrolled in SWOG trials of oral chemotherapy
    Lauren A. Marcath
    Colin M. Finley
    Siu Fun Wong
    Daniel L. Hertz
    BMC Cancer, 21
  • [7] Drug-drug interactions in pediatric oncology patients
    Balk, T. E.
    van der Sijs, I. H.
    van Gelder, T.
    Janssen, J. J. B.
    van der Sluis, I. M.
    van Leeuwen, R. W. F.
    Engels, F. K.
    PEDIATRIC BLOOD & CANCER, 2017, 64 (07)
  • [8] Medication reconciliation in oncology and monitoring of preventable drug interactions
    Tenti, Elena
    Schirone, Alessto
    Passardi, Alessandro
    Gardini, Andrea Casadei
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2015, 36 : S26 - S26
  • [9] Concomitant drugs with low risks of drug-drug interactions for use in oncology clinical trials
    Ranchon, Florence
    Vial, Thierry
    Rioufol, Catherine
    Henin, Emilie
    Falandry, Claire
    Freyer, Gilles
    Trillet-Lenoir, Veronique
    Le Tourneau, Christophe
    You, Benoit
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 94 (02) : 189 - 200
  • [10] Medications reconciliation to detect drug-drug interactions (DDI) - impact on medication regimen during geriatric hospitalization
    Barak-Tsafrir, O.
    Tellem, R.
    Cialic, R.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2016, 64 : S73 - S74
12345